Mirae Asset Global Etfs Holdings Ltd. Applied Therapeutics Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 57,557 shares of APLT stock, worth $20,720. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,557
Previous 55,108
4.44%
Holding current value
$20,720
Previous $46,000
39.13%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding APLT
# of Institutions
94Shares Held
103MCall Options Held
176KPut Options Held
165K-
Vestal Point Capital, LP New York, NY11.5MShares$4.14 Million0.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$4.06 Million6.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.4MShares$3.74 Million0.0% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$2.81 Million2.55% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$2.37 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $17.3M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...